- date: 10/2025
  description: >-
    [CAMP](https://arxiv.org/abs/2407.09030?) is accepted on [npj Artificial Intelligence](https://www.nature.com/npjai/).
- date: 07/2025
  description: >-
    [VLEER](https://arxiv.org/abs/2502.20850), a novel method for WSI representation with explainability, is accepted at [MICCAI-Workshop 2025](https://imimic-workshop.com/).
- date: 06/2025
  description: >-
    [Ano-NAViLa](https://arxiv.org/abs/2508.15256), a model for detecting anomalous pathology, is accepted at ICCV 2025.
- date: 06/2025
  description: >-
    [AnoPILaD](https://arxiv.org/abs/2508.15236v1),the unsupervised method for anomaly detection in lymph nodes, is accepted at [MICCAI 2025](https://conferences.miccai.org/2025/en/).
- date: 04/2025
  description: >-
    I will start my CS PhD program at [Stony Brook University](https://www.cs.stonybrook.edu/) from Fall 2025.
- date: 03/2025
  description: >-
    [VLEER](https://arxiv.org/abs/2502.20850), an explainable framework for WSI representation, is released.
- date: 02/2025
  description: >-
    [2DMamba](https://arxiv.org/abs/2412.00678) is accepted at CVPR 2025.
- date: 02/2025
  description: >-
    I obtained the Master of Science from Korea University, Seoul, South Korea.
- date: 12/2024
  description: >-
    [2DMamba](https://arxiv.org/abs/2412.00678), a 2D Mamba-based method for vision taks, has been released.
- date: 11/2024
  description: >-
    Defensed my Master's thesis.
- date: 10/2024
  description: >-
    Ranked 6th in [MICCAI 2024-LEOPARD](https://leopard.grand-challenge.org/leopard/) for predicting biochemical recurrence of prostate cancer.
- date: 08/2024
  description: >-
    Received the KU Foreign Global Leader Scholarship for excellent GPA, research projects, and publications.
- date: 05/2024
  description: >-
    [TQx](http://arxiv.org/abs/2407.07360) has been accepted at MICCAI 2024 (Early accept, top 11%).
- date: 03/2024
  description: >-
    Received the BK21 Scholarship for excellent research projects and publications.
- date: 09/2023
  description: >-
    [GPC](http://arxiv.org/abs/2407.09035) has been accepted to MICCAI-MedAGI 2023 with "Best Paper Honorable Mention".
